EcoDrugPlus

Cytochrome P450

Ensembl ID : AGAP028019
Gene Symbol: CYP4H18
1 External references
241 Possible Orthologues:

Cytochrome P450

Ensembl ID : AGAP000192
Gene Symbol: CYP4C26
1 External references
140 Possible Orthologues:

Cytochrome P450

Ensembl ID : AGAP010414
Gene Symbol: CYP4C28
1 External references
333 Possible Orthologues:

Cytochrome P450

Ensembl ID : AGAP009241
Gene Symbol: CYP4C36
2 External references
140 Possible Orthologues:

Cytochrome P450

Ensembl ID : AGAP009240
Gene Symbol: CYP4C35
1 External references
140 Possible Orthologues:

Cytochrome P450

Ensembl ID : AGAP009246
Gene Symbol: CYP4C27
1 External references
140 Possible Orthologues:

Cytochrome P450

Ensembl ID : AGAP008358
Gene Symbol: CYP4H17
1 External references
241 Possible Orthologues:

Cytochrome P450

Ensembl ID : AGAP008356
Gene Symbol: CYP4H16
2 External references
241 Possible Orthologues:

Galectin 10

Ensembl ID : AGAP001197
Gene Symbol: GALE10
1 External references
185 Possible Orthologues:

Galectin 4

Ensembl ID : AGAP011278
Gene Symbol: GALE4
1 External references
184 Possible Orthologues:

Galectin 5

Ensembl ID : AGAP011287
Gene Symbol: GALE5
1 External references
184 Possible Orthologues:

Galectin 9

Ensembl ID : AGAP013132
Gene Symbol: GALE9
1 External references
184 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).